Gastrointestinal Stromal Tumor (GIST) is a rare intra-abdominal tumor, characterized by a specific histological and immunohistochemical pattern. These tumors affect with higher frequency stomach and small bowel and occur at a median age of 60 years with a slight male predominance. An early stage of GIST often don’t cause any symptoms, so most GISTs are diagnosed in later stages of the disease. We report a case of GIST diagnosed only with clinical data and positron emission tomography (PET). We demonstrate the usefulness of neo-adjuvant treatment with Imatinib mesylate, a newly developed tyrosine kinase receptor inhibitor. The neoadjuvant treatment with Imatinib reduced the mass size and vascularization, making possible a surgical approach.
|Titolo:||The neo-adiuvant treatment in gastrointestinal stromal tumor|
|Data di pubblicazione:||2010|
|Citazione:||The neo-adiuvant treatment in gastrointestinal stromal tumor / CATANIA V.; CONSOLI A; CAVALLARO A; LIARDO RL; MALAGUARNERA M. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - 14(2010), pp. 727-730.|
|Appare nelle tipologie:||1.1 Articolo in rivista|